Ischemic cholangiopathy

Seminars in Liver Disease

Volumn 28, Issue 3, 2008, Pages 235-

  Deltenre, Pierre ^a,b   Valla, Dominique Charles ^c  

^a Hospital de Jolimont   (Belgium)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c BEAUJON HOSPITAL   (France)

Author keywords

Hepatic artery thrombosis; Hereditary hemorrhagic telangiectasia; Ischemic cholangitis; Liver transplantation; Peribiliary plexus

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOLYTIC AGENT; GELATIN SPONGE; IODINATED POPPYSEED OIL; URSODEOXYCHOLIC ACID; VITAMIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTERY THROMBOSIS; BILE DUCT; BILE DUCT DISEASE; BILE DUCT INJURY; BILE DUCT OBSTRUCTION; BILIARY CIRRHOSIS; BILIARY TRACT DRAINAGE; BILOMA; BLOOD CLOTTING DISORDER; CHOLESTASIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS INFECTION; DECOMPRESSION; DRUG MEGADOSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FIBRINOLYTIC THERAPY; GALLSTONE; HEPATIC ARTERY; HEPATOJEJUNOSTOMY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; ISCHEMIA; ISCHEMIC CHOLANGIOPATHY; KIDNEY FAILURE; LABORATORY TEST; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER METASTASIS; LIVER TRANSPLANTATION; NEEDLE BIOPSY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERCUTANEOUS DRAINAGE; POLYARTERITIS NODOSA; PRIORITY JOURNAL; PROGNOSIS; SCLEROSING CHOLANGITIS; SEPSIS; SEPTIC SHOCK; SHORT SURVEY; TREATMENT OUTCOME; VASCULARIZATION; VATER PAPILLOTOMY;

EID: 52949093144     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0028-1085092     Document Type: Short Survey

References (110)

1. Sherlock S. Overview of chronic cholestatic conditions in adults: terminology and definitions. Clin Liver Dis 1998;2: 217-233 vii
2. Deltenre P, Valla DC. Ischemic cholangiopathy. J Hepatol 2006;44:806-817
3. Batts KP. Ischemic cholangitis. Mayo Clin Proc 1998;73: 380-385
4. Northover JM, Terblanche J. A new look at the arterial supply of the bile duct in man and its surgical implications. Br J Surg 1979;66:379-384
5. Takasaki S, Hano H. Three-dimensional observations of the human hepatic artery (arterial system in the liver). J Hepatol 2001;34:455-466
6. Ekataksin W, Zou ZZ, Wake K, et al. The hepatic microcirculatory subunits: an over-three-century-long search for the missing link between an exocrine unit and an endocrine unit in mammalian liver nodules. In: Motta PM, ed. Recent Advances in Microscopy of Cells, Tissues and Organs. Rome: University of Rome La Sapienza Press; 1997:375-380
7. Mays ET. Observations and management after hepatic artery ligation. Surg Gynecol Obstet 1967;124:801-807
8. Kim DK, Kinne DW, Fortner JG. Occlusion of the hepatic artery in man. Surg Gynecol Obstet 1973;136:966-968
9. Bengmark S, Rosengren K. Angiographic study of the collateral circulation to the liver after ligation of the hepatic artery in man. Am J Surg 1970;119:620-624
10. Redman HC, Reuter SR. Arterial collaterals in the liver hilus. Radiology 1970;94:575-579
11. Mays ET, Wheeler CS. Demonstration of collateral arterial flow after interruption of hepatic arteries in man. N Engl J Med 1974;290:993-996
12. Koehler RE, Korobkin M, Lewis F. Arteriographic demonstration of collateral arterial supply to the liver after hepatic artery ligation. Radiology 1975;117:49-54
13. Fisher A, Miller CH. Ischemic-type biliary strictures in liver allografts: the Achilles heel revisited? Hepatology 1995;21: 589-591
14. Demachi H, Matsui O, Takashima T. Scanning electron microscopy of intrahepatic microvasculature casts following experimental hepatic artery embolization. Cardiovasc Intervent Radiol 1991;14:158-162
15. Demachi H, Matsui O, Kawamori Y, Ueda K, Takashima T. The protective effect of portoarterial shunts after experimental hepatic artery embolization in rats with liver cirrhosis. Cardiovasc Intervent Radiol 1995;18:97-101
16. Fouassier L, Beaussier M, Schiffer E, et al. Hypoxia-induced changes in the expression of rat hepatobiliary transporter genes. Am J Physiol Gastrointest Liver Physiol 2007;293:G25-G35
17. Wagner M, Zollner G, Trauner M. Ischemia and cholestasis: more than (just) the bile ducts! Transplantation 2008;85:1083-1085
18. Hohn D, Melnick J, Stagg R, et al. Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridine. J Clin Oncol 1985;3:98-102
19. Shea WJ Jr, Demas BE, Goldberg HI, et al. Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation. AJR Am J Roentgenol 1986;146:717-721
20. Aldrighetti L, Arru M, Ronzoni M, et al. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer. Hepatogastroenterology 2001;48:1302-1307
21. Terblanche J, Allison HF, Northover JM. An ischemic basis for biliary strictures. Surgery 1983;94:52-57
22. Valente JF, Alonso MH, Weber FL, Hanto DW. Late hepatic artery thrombosis in liver allograft recipients is associated with intrahepatic biliary necrosis. Transplantation 1996;61:61-65
23. Abbasoglu O, Levy MF, Vodapally MS, et al. Hepatic artery stenosis after liver transplantation-incidence, presentation, treatment, and long term outcome. Transplantation 1997;63:250-255
24. Siegel JH, Ramsey WH. Endoscopic biliary stent placement for bile duct stricture after hepatic artery infusion of 5-FUDR. J Clin Gastroenterol 1986;8:673-676
25. Gelbmann CM, Rummele P, Wimmer M, et al. Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol 2007;102:1221-1229
26. Ludwig J, Kim CH, Wiesner RH, Krom RA. Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy? Hepatology 1989;9:215-218
27. Pettavel J, Gardiol D, Bergier N, Schnyder P. Fatal liver cirrhosis associated with long-term arterial infusion of floxuridine. Lancet 1986;2:1162-1163
28. Dikengil A, Siskind BN, Morse SS, et al. Sclerosing cholangitis from intraarterial floxuridine. J Clin Gastro-enterol 1986;8:690-693
29. Pitre J, Houssin D, Louvel A, et al. Ectasing cholangitis and secondary biliary cirrhosis following intra-arterial hepatic chemotherapy. Treatment by liver transplantation. Gastroenterol Clin Biol 1991;15:350-354
30. Makuuchi M, Sukigara M, Mori T, et al. Bile duct necrosis: complication of transcatheter hepatic arterial embolization. Radiology 1985;156:331-334
31. Richardet JP, Lons T, Sibony M, et al. Secondary sclerosing cholangitis and chemo-embolization with lipiodol. Gastroenterol Clin Biol 1994;18:168-171
32. Hasegawa K, Kubota K, Aoki T, et al. Ischemic cholangitis caused by transcatheter hepatic arterial chemoembolization 10 months after resection of the extrahepatic bile duct. Cardiovasc Intervent Radiol 2000;23:304-306
33. Iwata M, Sasaki M, Harada K, et al. Intrahepatic cholangitis and arteritis after transcatheter arterial embolization in a patient with tumor-like lesion-associated autoimmune hepatitis. Pathol Res Pract 2001;197:59-63
34. Herrmann G, Lorenz M, Kirkowa-Reimann M, Hottenrott C, Hubner K. Morphological changes after intra-arterial chemotherapy of the liver. Hepatogastroenterology 1987;34: 5-9
35. Pettavel J. Intra-arterial chemotherapy using a pump. Antibiot Chemother 1988;40:36-40
36. Bognel C, Degott C, Rougier P, et al. Anatomo-pathologic study of hepatic toxicity in intra-arterial hepatic chemotherapy. Gastroenterol Clin Biol 1989;13:125-131
37. Kobayashi S, Nakanuma Y, Matsui O. Histopathology of portal tracts in livers after transcatheter arterial chemoembolization therapy for hepatocellular carcinoma. J Gastroenterol Hepatol 1994;9:45-54
38. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359: 1734-1739
39. Kemeny N, Daly J, Reichman B, et al. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987;107:459-465
40. Chang AE, Schneider PD, Sugarbaker PH, et al. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206:685-693
41. Kemeny N, Daly J, Oderman P, et al. Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma. J Clin Oncol 1984;2:595-600
42. Daly JM, Kemeny N, Oderman P, Botet J. Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. Arch Surg 1984;119:936-941
43. Johnson LP, Rivkin SE. The implanted pump in metastatic colorectal cancer of the liver. Risk versus benefit. Am J Surg 1985;149:595-598
44. Kemeny N, Seiter K, Conti JA, et al. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma. New dose schedules and survival update. Cancer 1994;73:1134-1142
45. Tarazov PG, Polysalov VN, Prozorovskij KV, Grishchenkova IV, Rozengauz EV. Ischemic complications of transcatheter arterial chemoembolization in liver malignancies. Acta Radiol 2000;41:156-160
46. Harada T, Matsuo K, Inoue T, Tamesue S, Nakamura H. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 1996;224: 4-9
47. Benhamou Y, Caumes E, Gerosa Y, et al. AIDS-related cholangiopathy. Critical analysis of a prospective series of 26 patients. Dig Dis Sci 1993;38:1113-1118
48. Eidelberg D, Sotrel A, Vogel H, et al. Progressive polyradiculopathy in acquired immune deficiency syndrome. Neurology 1986;36:912-916
49. Foucar E, Mukai K, Foucar K, Sutherland DE, Van Buren CT. Colon ulceration in lethal cytomegalovirus infection. Am J Clin Pathol 1981;76:788-801
50. Koeppen AH, Lansing LS, Peng SK, Smith RS. Central nervous system vasculitis in cytomegalovirus infection. J Neurol Sci 1981;51:395-410
51. Morgello S, Cho ES, Nielsen S, Devinsky O, Petito CK. Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature. Hum Pathol 1987;18:289-297
52. Rene E, Marche C, Chevalier T, et al. Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome. Dig Dis Sci 1988;33:741-750
53. Shintaku M, Inoue N, Sasaki M, et al. Cytomegalovirus vasculitis accompanied by an exuberant fibroblastic reaction in the intestine of an AIDS patient. Acta Pathol Jpn 1991; 41:900-904
54. Cello JP. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med 1989;86:539-546
55. Burt AD, Scott G, Shiach CR, Isles CG. Acquired immunodeficiency syndrome in a patient with no known risk factors: a pathological study. J Clin Pathol 1984;37: 471-474
56. Kavin H, Jonas RB, Chowdhury L, Kabins S. Acalculous cholecystitis and cytomegalovirus infection in the acquired immunodeficiency syndrome. Ann Intern Med 1986;104: 53-54
57. Blewitt RW, Brown CM, Wyatt JI. The pathology of acute hepatic disintegration in hereditary haemorrhagic telangiectasia. Histopathology 2003;42:265-269
58. Garcia-Tsao G, Korzenik JR, Young L, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000;343:931-936
59. DeCosse JJ, Rhodes RS, Wentz WB, et al. The natural history and management of radiation induced injury of the gastrointestinal tract. Ann Surg 1969;170:369-384
60. Chandrasekhara KL, Iyer SK. Obstructive jaundice due to radiation-induced hepatic duct stricture. Am J Med 1984; 77:723-724
61. Cherqui D, Palazzo L, Piedbois P, et al. Common bile duct stricture as a late complication of upper abdominal radiotherapy. J Hepatol 1994;20:693-697
62. Nakakubo Y, Kondo S, Katoh H, Shimizu M. Biliary stricture as a possible late complication of radiation therapy. Hepatogastroenterology 2000;47:1531-1532
63. Martenson JA Jr, Gunderson LL, Buskirk SJ, et al. Hepatic duct stricture after radical radiation therapy for biliary cancer: recurrence or fibrosis? Mayo Clin Proc 1986;61:530-536
64. Doppman JL, Dunnick NR, Girton M, Fauci AS, Popovsky MA. Bile duct cysts secondary to liver infarcts: report of a case and experimental production by small vessel hepatic artery occlusion. Radiology 1979;130:1-5
65. Goritsas CP, Repanti M, Papadaki E, Lazarou N, Andonopoulos AP. Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa. J Hepatol 1997;26:727-730
66. Griffith GC, Vural IL. A correlation of clinical and postmortem findings in seventeen cases. Circulation 1951; 3:481-491
67. Reidbord HE, McCormack LJ, O'Duffy JD. Necrotizing angiitis. II. Findings at autopsy in twenty-seven cases. Cleve Clin Q 1965;32:191-204
68. Barquist ES, Goldstein N, Zinner MJ. Polyarteritis nodosa presenting as a biliary stricture. Surgery 1991;109:16-19
69. Hashikura Y, Makuuchi M, Kawasaki S, et al. Benign stricture of the intrahepatic bile duct with arterial involvement. Hepatogastroenterology 1994;41:79-81
70. Saiura A, Umekita N, Inoue S, et al. Benign biliary stricture associated with atherosclerosis. Hepatogastroenterology 2001;48:81-82
71. Char D, Mohan E, George R, Gambarin S. Common bile duct necrosis after cardiac catheterization. Am J Gastro-enterol 1998;93:2597-2598
72. Chen WJ, Ying DJ, Liu ZJ, He ZP. Analysis of the arterial supply of the extrahepatic bile ducts and its clinical significance. Clin Anat 1999;12:245-249
73. Hillaire S, Gardin C, Attar A, et al. Cholangiopathy and intrahepatic stones in sickle cell disease: coincidence or ischemic cholangiopathy? Am J Gastroenterol 2000;95:300-301
74. Gear JH, Meyers KE, Steele M. Kawasaki disease manifesting with acute cholangitis. A case report. S Afr Med J 1992;81:31-33
75. Viola S, Meyer M, Fabre M, et al. Ischemic necrosis of bile ducts complicating Schonlein-Henoch purpura. Gastroenterology 1999;117:211-214
76. Alberti-Flor JJ, Jeffers L, Schiff ER. Primary sclerosing cholangitis occurring in a patient with systemic lupus erythematosus and diabetes mellitus. Am J Gastroenterol 1984;79:889-891
77. Lamy P, Valla D, Bourgeois P, Rueff B, Benhamou JP. Primary sclerosing cholangitis and systemic lupus erythematosus. Gastroenterol Clin Biol 1988;12:962-964
78. Audan A, Bruley Des Varannes S, Georgelin T, et al. Primary sclerosing cholangitis and systemic lupus erythematosus. Gastroenterol Clin Biol 1995;19:123-126
79. Heyman SN, Spectre G, Aamar S, et al. Autoimmune cholangiopathy associated with systemic lupus erythematosus. Liver 2002;22:102-106
80. Kirby DF, Blei AT, Rosen ST, Vogelzang RL, Neiman HL. Primary sclerosing cholangitis in the presence of a lupus anticoagulant. Am J Med 1986;81:1077-1080
81. Le Thi Huong D, Valla D, Franco D, et al. Cholangitis associated with paroxysmal nocturnal hemoglobinuria: another instance of ischemic cholangiopathy? Gastroenterology 1995;109:1338-1343
82. Scheurlen M, Mork H, Weber P. Hypereosinophilic syndrome resembling chronic inflammatory bowel disease with primary sclerosing cholangitis. J Clin Gastroenterol 1992;14:59-63
83. Engler S, Elsing C, Flechtenmacher C, et al. Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders. Gut 2003;52:688-693
84. Putensen C, Wrigge H, Hering R. The effects of mechanical ventilation on the gut and abdomen. Curr Opin Crit Care 2006;12:160-165
85. Trager K, Radermacher P, Georgieff M. PEEP and hepatic metabolic performance in septic shock. Intensive Care Med 1996;22:1274-1275
86. Starzl TE, Demetris AJ. Liver transplantation: a 31-year perspective. Part I. Curr Probl Surg 1990;27:49-116
87. Demetris AJ. Ischemic cholangitis. Mayo Clin Proc 1992; 67:601-602
88. Ludwig J, Batts KP, MacCarty RL. Ischemic cholangitis in hepatic allografts. Mayo Clin Proc 1992;67:519-526
89. Sebagh M, Farges O, Kalil A, et al. Sclerosing cholangitis following human orthotopic liver transplantation. Am J Surg Pathol 1995;19:81-90
90. Silva MA, Jambulingam PS, Gunson BK, et al. Hepatic artery thrombosis following orthotopic liver transplantation: a 10-year experience from a single centre in the United Kingdom. Liver Transpl 2006;12:146-151
91. Drazan K, Shaked A, Olthoff KM, et al. Etiology and management of symptomatic adult hepatic artery thrombosis after orthotopic liver transplantation (OLT). Am Surg 1996;62:237-240
92. Tzakis AG, Gordon RD, Shaw BW Jr, Iwatsuki S, Starzl TE. Clinical presentation of hepatic artery thrombosis after liver transplantation in the cyclosporine era. Transplantation 1985;40:667-671
93. Gunsar F, Rolando N, Pastacaldi S, et al. Late hepatic artery thrombosis after orthotopic liver transplantation. Liver Transpl 2003;9:605-611
94. Pinna AD, Smith CV, Furukawa H, Starzl TE, Fung JJ. Urgent revascularization of liver allografts after early hepatic artery thrombosis. Transplantation 1996;62:1584-1587
95. Nakamura N, Nishida S, Neff GR, et al. Intrahepatic biliary strictures without hepatic artery thrombosis after liver transplantation: an analysis of 1,113 liver transplantations at a single center. Transplantation 2005;79:427-432
96. Ko WF, Cello JP, Rogers SJ, Lecours A. Prognostic factors for the survival of patients with AIDS cholangiopathy. Am J Gastroenterol 2003;98:2176-2181
97. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989;7:1646-1654
98. Gotoh M, Monden M, Sakon M, et al. Bile duct necrosis after partial hepatectomy and transcatheter hepatic arterial embolization. AJR Am J Roentgenol 1990;154:1124
99. Kim BW, Won JH, Lee BM, et al. Intraarterial thrombolytic treatment for hepatic artery thrombosis immediately after living donor liver transplantation. Transplant Proc 2006;38:3128-3131
100. Rogers J, Chavin KD, Kratz JM, et al. Use of autologous radial artery for revascularization of hepatic artery thrombosis after orthotopic liver transplantation: case report and review of indications and options for urgent hepatic artery reconstruction. Liver Transpl 2001;7:913-917
101. Zhou J, Fan J, Wang JH, et al. Continuous transcatheter arterial thrombolysis for early hepatic artery thrombosis after liver transplantation. Transplant Proc 2005;37:4426-4429
102. Hintze RE, Adler A, Veltzke W, et al. Endoscopic management of biliary complications after orthotopic liver transplantation. Hepatogastroenterology 1997;44:258-262
103. Neuhaus P, Blumhardt G, Bechstein WO, et al. Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg 1994;219:426-434
104. Theilmann L, Kuppers B, Kadmon M, et al. Biliary tract strictures after orthotopic liver transplantation: diagnosis and management. Endoscopy 1994;26:517-522
105. Li S, Stratta RJ, Langnas AN, et al. Diffuse biliary tract injury after orthotopic liver transplantation. Am J Surg 1992; 164:536-540
106. Schlitt HJ, Meier PN, Nashan B, et al. Reconstructive surgery for ischemic-type lesions at the bile duct bifurcation after liver transplantation. Ann Surg 1999;229:137-145
107. Alves A, Farges O, Nicolet J, et al. Incidence and consequence of an hepatic artery injury in patients with postcholecystectomy bile duct strictures. Ann Surg 2003; 238:93-96
108. Bismuth H, Lazorthes F. 83rd Congress of the French Surgical Society (Paris, 21-24 September 1981). Second report. Operative injuries of the common biliary duct. J Chir (Paris) 1981;118:601-609
109. Northover J, Terblanche J. Bile duct blood supply. Its importance in human liver transplantation. Transplantation 1978;26:67-69
110. Bauer T, Britton P, Lomas D, et al. Liver transplantation for hepatic arteriovenous malformation in hereditary haemorrhagic telangiectasia. J Hepatol 1995;22:586-590